Search
GTS-21
go.drugbank.com/drugs/DB05708Investigationalcontrolled study in healthy adults, GTS-21 also demonstrated cognitive enhancement across all doses, with a statistically significant improvement in attention related and memory related tasks (Kitagawa, et
Radium Ra 223 dichloride
go.drugbank.com/drugs/DB08913ApprovedInvestigationalIt was first approved by the FDA in May 2013 and is currently marketed under the brand name Xofigo, which was formerly called Alpharadin.
Sincalide
go.drugbank.com/drugs/DB09142ApprovedIt is identified as the 8-amino acid C-terminal segment of cholecystokinin and is also known as _CCK-8_.
GTI 2040
go.drugbank.com/drugs/DB05801InvestigationalIt belongs to the family of drugs called antisense oligonucleotides.
Quercetin
go.drugbank.com/drugs/DB04216InvestigationalIt is an antioxidant, like many other phenolic heterocyclic compounds. Glycosylated forms include RUTIN and quercetrin.
CA-074 methyl ester
go.drugbank.com/drugs/DB07223ExperimentalIt is converted by cellular esterases to CA-074.[A258234,A258239]
{[5-(5-nitro-2-furyl)-1,3,4-oxadiazol-2-yl]thio}acetic acid
go.drugbank.com/drugs/DB08098ExperimentalIt targets the protein aldose reductase.
Trifluoroethanol
go.drugbank.com/drugs/DB03226ExperimentalIt is also used in various pharmaceutical, chemical and engineering applications.
Gavorestat
go.drugbank.com/drugs/DB16707InvestigationalGavorestat is under investigation in clinical trial NCT04902781 (Clinical Benefit, Safety, PK and PD Study of AT-007 in Pediatric Subjects With Classic Galactosemia).
Synonyms: AT-007